Professional Documents
Culture Documents
Mohsin Synopsis
Mohsin Synopsis
By
for
MD PEDIATRIC MEDICINE
under supervision of
Nationality: CNIC #:
Pakistani 36401-4115197-5
Address:
Phone #: Email:
03046585891 drmohsan44@gmail.com
2 House Physician Peads Unit-I, Services Hospital Lahore 07-05 -2016 to 06-08-2016
Table of Contents
Project summary ..........................................................................................................................................7
Introduction .............................................................................................................................................8
Literature review ......................................................................................................................................9
Hypothesis .................................................................................................................................................11
Null hypothesis .......................................................................................................................................11
Alternate hypothesis ...................................................................................................................................11
Objective ...................................................................................................................................................12
Operational definition ............................................................................................................................13
Material and methods ............................................................................................................................14
Study design............................................................................................................................................14
Setting .........................................................................................................................................................14
Duration of study ...................................................................................................................................14
Sample size ..................................................................................................................................................14
Sampling technique.................................................................................................................................14
Inclusion criteria ..........................................................................................................................................14
Exclusion criteria .....................................................................................................................................14
Data collection procedure ...........................................................................................................................15
Data analysis ...........................................................................................................................................16
Outcome and utilization .........................................................................................................................17
Limitations .............................................................................................................................................18
Bibliography ...........................................................................................................................................19
Ethical declaration ..................................................................................................................................21
Consent (English) ....................................................................................................................................22
Estimated cost of project ........................................................................................................................24
Questionnaire ........................................................................................................................................25
Plan of work (Gantt chart) ......................................................................................................................26
List of Abbreviations:
Project Summary:
Umbilical cord infection (omphalitis) is a risk factor for neonatal sepsis and mortality in low-resource settings
where home deliveries are common. Up to half of neonatal deaths in high mortality settings are due to
infections, many of which can originate through the freshly cut umbilical cord stump. The aim of this study is
to compare the outcome of application of chlorhexidine on umbilical cord versus dry cord care in neonates.
Neonates will be randomly allocated in two groups by using lottery method. The neonates in case group will
get an application of the 7% chlorhexidine digluconate gel (delivering 4% chlorhexidine) on cord stump on
their first day of life by the researcher and their mothers will be trained to do so once daily for first week of
life. Guardians or mother of the neonates in control group will be advised to keep the cord stump of their
neonates dry and clean without applying anything on it. They will be called for follow up on 14th day of life
and signs of omphalitis will be noted according to operational definition. Neonates who will develop
omphalitis, will be managed as per hospital protocol. The other outcome will be cord separation time and
incidence of neonatal sepsis. Data will be entered and analyzed by SPSS v25.0. Quantitative variables like
gestational age, weight of baby and cord separation time will be presented as Mean±S.D. Qualitative variables
like gender, residential area, socio-economic status, neonatal sepsis and omphalitis will be presented as
frequencies and percentages. Both groups will be compared for omphalitis and neonatal sepsis by using chi-
square test taking p-va1ue ≤0.05 as significant. Both groups will be compared for cord separation time by using
third of annual global neonatal deaths are caused by infections alone(McAllister et al., 2019). Tracking of
bacteria along the umbilical vessels in newly cut umbilical cord may lead to septicemia that can result in
neonatal morbidity and mortality, especially in developing countries(Stewart and Benitz, 2016). Pakistan has a
high neonatal mortality rate (NMR) of 53 per 1000 live births with sepsis as its major contributor (30% of
Unhygienic practices are prevalent in rural areas of the country. These include cutting the umbilical cord with
household knife, and applying unsafe substances like ash, crushed lead ore called surma, oil, turmeric and even
cow dung. This leads to high incidence of neonatal infections and deaths(Khanam et al., 2018). Chlorhexidine
is safe and inexpensive antiseptic and requires minimal training and skill and should strongly be considered for
adoption wherever home births occur(Mukunya et al., 2018).Studies have shown that chlorhexidine reduces
cord colonization with pathogens and thus omphalitis and sepsis. Omphalitis is a deadly infection of umbilical
cord and causes significant morbidity and mortality both historically and in areas where health care is less
readily available. Local data on this subject is available only in the form of a single published study, done in
rural areas of Dadu. Although it also shows the beneficial effects of this drug but results are variable in
different studies and this drug is not yet approved for cord care by local authorities in Pakistan due to non-
Through this study, we will collect more and accurate local evidence that 4% chlorhexidine is good enough, in
reducing omphalitis, to be adapted as standard operating procedure for newborn cord care in Pakistan. By
doing this study, we will be able to implement the regular use of chlorhexidine in Pakistan for newborn to
Unhygienic practices are prevalent in rural areas of the country. These include cutting the umbilical cord with
household knife, and applying unsafe substances like ash, crushed lead ore called surma, oil, turmeric and even
cow dung. This leads to high incidence of neonatal infections and deaths(Khanam et al., 2018). Chlorhexidine
is safe and inexpensive antiseptic and requires minimal training and skill and should strongly be considered for
adoption wherever home births occur(Mukunya et al., 2018).Studies have shown that chlorhexidine reduces
A trial conducted by Sajid et al., in rural Pakistan showed that the rate of omphalitis was 3.2% with
chlorhexidine while 7.6% without chlorhexidine (dry cord). The factorial analysis indicated a reduction in risk
of omphalitis with chlorhexidine application (risk ratio [RR]=0.58, 95% CI 0.41-0.82; p=0.002)(Soofi et al.,
2012). El Arifeen et al., supported the evidence and reported that the rate of omphalitis was 18.5% with
chlorhexidine while 22.6% without chlorhexidine (dry cord). The difference was significant (p<0.005)(El
Imdad A et al., observed that, chlorhexidine application on cord stump showed a reduction in omphalitis
ranged from 27% to 56% depending on the severity of the infection compared to dry care cord(Imdad et al.,
2013).Gathwala et al in North India showed that, chlorhexidine reduces neonatal sepsis in NICU when used on
umbilical cord(Gathwala et al., 2013).Rationale of this study is to compare the outcome of application of
chlorhexidine on umbilical cord versus dry cord care in neonates. Literature has shown that application of
Omphalitis is a deadly infection of umbilical cord and causes significant morbidity and mortality both
historically and in areas where health care is less readily available. Local data on this subject is available only
in the form of a single published study, done in rural areas of Dadu.Although it also shows the beneficial
effects of this drug but results are variable in different studies and this drug is not yet approved for cord care by
4% chlorhexidine significantly reduce the risk of umbilical infection in both single and multiple cord cleansing
groups as compared to clean and dry cord care group. (Khairruzaman et al.,2018) Dry cord care is effective in
countries with low infant mortality rate and in hospital births. However, 4% chlorhexidine for umbilical cord
care protects against omphalitis in home births, in countries with a high infant mortality rate. (Medina et
al.,2019) Chlorhexidine use was effective to lower neonatal omphalitis compared to those who received
dry cord care although cord detachment time was prolonged in former group. So it may be used regularly in our
common practice whether in hospital settings or in home births and it should be included as standard protocol
in essential newborn care in our setup where NMR is quite high (Ishaq et al.,2020).
The data was collected from 100 neonates. All the demographic values which include age, gender, gestational
age and mode of delivery were calculated. According to baseline values the birth weight of chlorhexidine
group was 1.87 ± 0.463 kg and dry cord group was 1.69 ± 0.421 kg. Umbilical sepsis is observed in only 1
patient in group I and in 3 patients in group II. Only single mortality was observed in group I and in 6 neonates
in group II. Conclusion: It is concluded that chlorhexidine umbilical cord care is more appropriate than the
Nine trials were included, from six countries: Zambia, Tanzania, Bangladesh, Nepal, India and Pakistan, with a
total of 257,153 participants. Five studies (N = 119,833) reported neonatal mortality. There was a 21%
reduction in neonatal mortality among with 4% chlorhexidine application: pooled RR (95% CI) 0.79
(0.69–0.90), P = 0.0005. The incidence of omphalitis was decreased by 35% with 4% chlorhexidine (6
studies, N = 108,263): pooled RR (95% CI) 0.65 (0.56–0.75), P = 0.00001. Chlorhexidine application delayed
the umbilical cord separation time (4 studies, N = 28,917): mean difference (95% CI) 2.71 (2.63–2.78) days.
In conclusion, this systematic review found that topical application of 4% chlorhexidine to the umbilical cord
stump of newborn infants in lower income countries significantly reduces the incidence of neonatal mortality.
Chlorhexidine also reduces the incidence of omphalitis, but prolongs umbilical cord separation time. (Roba et
al.,2019)
Hypothesis:
NULL HYPOTHESIS
There is no difference in the incidence of omphalitis, cord separation time and neonatal sepsis with application
ALTERNATE HYPOTHESIS
There is a difference in the incidence of omphalitis, cord separation time and neonatal sepsis with application
It will be measured as the presence of redness, swelling (edema) and pus formation (any one or more) either on
the cord stump or the skin at the base of stump on clinical examination which will be done on 14th day of
experimental work.
Neonatal sepsis
Diagnosis of sepsis required presence of any two or more systemic inflammatory response syndrome criteria as
below:
Irritable or lethargic
Where infection is considered to be the underlying cause (raised CRP, urine pus cells>5, X-ray findings)
Setting: The study will be conducted at Department of Pediatrics Medicine, Services Hospital, Lahore.
Sample Size:
Sample size of 96 patients (48 in each group) was estimated by 95% confidence level with 80% power of test
and taking expected percentage of sepsis as 2.86% with Chlorhexidine application and 21.43% in dry cord
Sample Selection:
Inclusion criteria:
Neonates of both genders born and discharged on their first day of life from nursery
Exclusion criteria:
Neonates with obvious anomalies of cord or congenital defects (on clinical examination)
Neonates having obvious morbidity at birth like birth asphyxia, poor Apgar score <7 at 5 minutes after
Methodology:
After approval from hospital ethical committee, neonates fulfilling inclusion and exclusion criteria will be
Neonates will be randomly allocated in two groups by using lottery method. The neonates in case group will
get an application of the 7% chlorhexidine gluconate gel (delivering 4% chlorhexidine) on cord stump on their
first day of life by the researcher and their mothers will be trained to do so once daily for first week of life.
Guardians or mother of the neonates in control group will be advised to keep the cord stump of their neonates
dry and clean without applying anything on it. They will be called for follow up on 14th day of life and signs of
Neonates who will develop omphalitis, will be managed as per hospital protocol. The other outcome will be
cord separation time and incidence of neonatal sepsis. The data will be collected by researcher himself in a pre-
and cord separation time will be presented as Mean±S.D. Qualitative variables like gender, residential area,
socio-economic status, neonatal sepsis and omphalitis will be presented as frequencies and percentages. Both
groups will be compared for omphalitis and neonatal sepsis by using chi-square test taking p-va1ue ≤0.05 as
significant. Both groups will be compared for cord separation time by using t-test taking p-va1ue ≤0.05 as
significant.
Outcome & Utilization:
OUTCOME
1. Omphalitis will be measured as the presence of redness, swelling (edema) and pus formation (any one
or more) either on the cord stump or the skin at the base of stump on clinical examination.
UTILIZATION
Result will help improve the better management of neonatal umbilical cord care and will help decrease the
Bibliography:
1. El Arifeen, S., Mullany, L.C., Shah, R., Mannan, I., Rahman, S.M., Talukder, M.R.R., Begum, N., Al-
Kabir, A., Darmstadt, G.L., Santosham, M. and Black, R.E., 2012. The effect of cord cleansing with
chlorhexidine on neonatal mortality in rural Bangladesh: a community-based, cluster-randomised
trial. The Lancet, 379(9820), pp.1022-1028.
2. Gathwala, G., Sharma, D. and Bhakhri, B.K., 2013. Effect of topical application of chlorhexidine for
umbilical cord care in comparison with conventional dry cord care on the risk of neonatal sepsis: a
randomized controlled trial. Journal of tropical pediatrics, 59(3), pp.209-213.
3. Imdad, A., Bautista, R.M.M., Senen, K.A.A., Uy, M.E.V., Mantaring III, J.B. and Bhutta, Z.A., 2013.
Umbilical cord antiseptics for preventing sepsis and death among newborns. Cochrane Database of
Systematic Reviews, (5).
4. Khan, S., Zaheer, S. and Safdar, N.F., 2019. Determinants of stunting, underweight and wasting among
children< 5 years of age: evidence from 2012-2013 Pakistan demographic and health survey. BMC
public health, 19(1), pp.1-15.
5. El Arifeen, S., Mullany, L.C., Shah, R., Mannan, I., Rahman, S.M., Talukder, M.R.R., Begum, N., Al-
Kabir, A., Darmstadt, G.L., Santosham, M. and Black, R.E., 2012. The effect of cord cleansing with
chlorhexidine on neonatal mortality in rural Bangladesh: a community-based, cluster-randomised
trial. The Lancet, 379(9820), pp.1022-1028.
6. McAllister, D.A., Liu, L., Shi, T., Chu, Y., Reed, C., Burrows, J., Adeloye, D., Rudan, I., Black, R.E.,
Campbell, H. and Nair, H., 2019. Global, regional, and national estimates of pneumonia morbidity and
mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. The Lancet
Global Health, 7(1), pp.e47-e57.
7. Mukunya, D., Haaland, M.E., Tumwine, J.K., Ndeezi, G., Namugga, O., Tumuhamye, J., Sommerfelt,
H., Rujumba, J., Tylleskar, T., Moland, K.M. and Nankabirwa, V., 2018. “We shall count it as a part of
kyogero”: acceptability and considerations for scale up of single dose chlorhexidine for umbilical cord
care in Central Uganda. BMC Pregnancy and Childbirth, 18(1), pp.1-9.
8. Soofi, S., Cousens, S., Imdad, A., Bhutto, N., Ali, N. and Bhutta, Z.A., 2012. Topical application of
chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal mortality in a rural
district of Pakistan: a community-based, cluster-randomised trial. The Lancet, 379(9820), pp.1029-
1036.
9. Stewart, D., Benitz, W., Watterberg, K.L., Cummings, J.J., Eichenwald, E.C., Poindexter, B.B., Aucott,
S.W., Goldsmith, J.P., Puopolo, K.M. and Wang, K.S., 2016. Umbilical cord care in the newborn
infant. Pediatrics, 138(3).
10. Shane, A.L., Sánchez, P.J. and Stoll, B.J., 2017. Neonatal sepsis. The lancet, 390(10104), pp.1770-
1780.
11. Khairuzzaman, M., Rouf, M.A., Sarker, M.M.A., Hossain, I., Matin, A., Mowla, G., Sarker, N.R.,
Mannan, M.A. and Shahidullah, M., 2018. Chlorhexidine Cleansing of the Umbilical Cord for
Prevention of Umbilical Infection: A Hospital based Study in Bangladesh. Bangladesh Journal of Child
Health, 42(1), pp.4-8.
12. López-Medina, M.D., Linares-Abad, M., López-Araque, A.B. and López-Medina, I.M., 2019. Dry care
versus chlorhexidine cord care for prevention of omphalitis. Systematic review with meta-
analysis. Revista Latino-Americana de Enfermagem, 27.
13. Ishaq, F., Jamil, A., Sajjad, M., Iftikhar, M., Zafar, M.A. and Anwar, A., 2020. Efficacy of 4%
chlorhexidine in preventing neonatal umbilical cord infection. Journal of Fatima Jinnah Medical
University, 14(03), pp.136-139.
14. Riaz, N., Tahir, R., Muntaha, S.T., Aziz, S. and Zulfqar, R., 2019. Comparison of Umbilical Cord Care:
chlorhexidine 4% versus dry cord care. Journal of Islamic International Medical College
(JIIMC), 14(1), pp.8-12.
15. Mohsin, R., Khan, P. and Naveed, M., 2021. Use of Chlorhexidine on Umbilicus in Prevention of
Neonatal Sepsis.
16. Roba, A.A., Tefera, M., Worku, T., Dasa, T.T., Estifanos, A.S. and Assefa, N., 2019. RETRACTED
ARTICLE: Application of 4% chlorhexidine to the umbilical cord stump of newborn infants in lower
income countries: a systematic review and meta-analysis. Maternal Health, Neonatology and
Perinatology, 5(1), pp.1-9.
Ethical Declaration
I undertake that: -
1. I will abide by the declaration of World Medical Association (WMA) made at Helsinki year 2013
regarding the ethical principles for medical research involving human subjects.
2. Informed consent of the patient or guardian shall be obtained after explaining any risk involved in the
procedure.
Name of project: comparison of local application of chlorhexidine vs dry cord care in neonates delivered
Purpose: To compare the outcome of application of chlorhexidine on umbilical cord versus dry cord care in
neonates
Procedure: Every patient will be explained the purpose of the study and requested to give her consent for
participation.
Time: 10 to 15 minutes will be required for every participant to participate in this study.
Possible Benefits: All the tests of the patients participated in this study will be guided for treatment.
Financial Consideration: There will be no financial burden on the patient. The financial benefits gained will
Confidentiality: All the records will be confidential and identity will be treated with confidentiality. The result
Termination from Participation: Every patient will have all the rights of getting excluded from the study
involve me with hazards. I have gone through the contents of the Performa and I am willing to cooperate for
1. Name of Patient
2. Signature of patient
Synopsis approval
Data collection
Name: _______________________________________________________________
Address: _____________________________________________________________
OUTCOME